Michael L. McCaleb

3.5k total citations
72 papers, 2.9k citations indexed

About

Michael L. McCaleb is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Michael L. McCaleb has authored 72 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 10 papers in Surgery. Recurrent topics in Michael L. McCaleb's work include Pancreatic function and diabetes (9 papers), Regulation of Appetite and Obesity (8 papers) and Receptor Mechanisms and Signaling (8 papers). Michael L. McCaleb is often cited by papers focused on Pancreatic function and diabetes (9 papers), Regulation of Appetite and Obesity (8 papers) and Receptor Mechanisms and Signaling (8 papers). Michael L. McCaleb collaborates with scholars based in United States, Canada and Australia. Michael L. McCaleb's co-authors include R.D. Myers, Linda J. Cornfield, Lynn B. DeCarr, Janet Sredy, Paul Gregor, Yun Feng, Kenneth L. Kees, Kurt Steiner, D H Lockwood and John J. Fitzgerald and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michael L. McCaleb

69 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael L. McCaleb United States	31	1.1k	821	610	491	425	72	2.9k
Michael D. Knierman United States	24	1.5k 1.3×	449 0.5×	651 1.1×	152 0.3×	594 1.4×	43	3.2k
Kohji Itoh Japan	31	1.6k 1.5×	1.0k 1.2×	223 0.4×	445 0.9×	1.3k 3.0×	162	4.5k
Ivar von Kügelgen Germany	39	2.5k 2.3×	1.3k 1.6×	968 1.6×	256 0.5×	857 2.0×	100	5.3k
Marlene A. Jacobson United States	35	2.4k 2.2×	1.8k 2.1×	386 0.6×	382 0.8×	444 1.0×	75	4.9k
James L. Ellis United States	31	1.3k 1.2×	653 0.8×	362 0.6×	252 0.5×	1.1k 2.7×	65	3.2k
Emmanuel Canet France	22	717 0.7×	379 0.5×	803 1.3×	188 0.4×	596 1.4×	44	2.0k
Canan G. Nebigil France	31	1.7k 1.5×	623 0.8×	160 0.3×	172 0.4×	408 1.0×	67	3.2k
Kiyoshi Furuichi Japan	28	1.9k 1.8×	468 0.6×	176 0.3×	115 0.2×	518 1.2×	52	3.5k
Mark E. Olah United States	28	2.3k 2.1×	1.1k 1.3×	251 0.4×	670 1.4×	302 0.7×	59	4.0k
Nigel P. Shankley United States	26	1.6k 1.5×	832 1.0×	146 0.2×	184 0.4×	610 1.4×	84	2.9k

Countries citing papers authored by Michael L. McCaleb

Since Specialization

Citations

This map shows the geographic impact of Michael L. McCaleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. McCaleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. McCaleb more than expected).

Fields of papers citing papers by Michael L. McCaleb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. McCaleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. McCaleb. The network helps show where Michael L. McCaleb may publish in the future.

Co-authorship network of co-authors of Michael L. McCaleb

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. McCaleb. A scholar is included among the top collaborators of Michael L. McCaleb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. McCaleb. Michael L. McCaleb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCaleb, Michael L., Steven G. Hughes, Tamar R. Grossman, et al.. (2025). Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen. Immunobiology. 230(2). 152876–152876. 2 indexed citations

Barbour, Sean, Michelle Hladunewich, Angela Makris, et al.. (2022). An Exploratory Trial of an Investigational RNA Therapeutic, IONIS-FB-LRx, for Treatment of IgA Nephropathy. Journal of the American Society of Nephrology. 33(11S). 800–800. 4 indexed citations

Boyer, David S., Jayashree Sahni, Sascha Fauser, et al.. (2021). Systemic Antisense Oligonucleotide Inhibition of Complement Factor B for Treatment of Geographic Atrophy: Results of a Placebo-controlled Phase 1 Dose-Escalation Study. Investigative Ophthalmology & Visual Science. 62(8). 196–196. 1 indexed citations

Jaffe, Glenn J., Jayashree Sahni, Sascha Fauser, et al.. (2020). Development of IONIS-FB-LRx to Treat Geographic Atrophy Associated with AMD. Investigative Ophthalmology & Visual Science. 61(7). 4305–4305. 23 indexed citations

Biasutto, Patricia, Peter Adamson, Kalyan Dulla, et al.. (2019). Allele specific knock-down of human P23H rhodopsin mRNA and prevention of retinal degeneration in humanized P23H rhodopsin knock-in mouse, following treatment with an intravitreal GAPmer antisense oligonucleotide (QR-1123). Investigative Ophthalmology & Visual Science. 60(9). 5719–5719. 5 indexed citations

Weng, Shih‐Yen, Xiaoyu Wang, Santosh Vijayan, et al.. (2018). IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal. EBioMedicine. 29. 92–103. 97 indexed citations

McCaleb, Michael L., Tamar R. Grossman, Peter Adamson, et al.. (2017). Systemic Pharmacodynamic Efficacy of a Complement Factor B Antisense Oligonucleotide in Preclinical and Phase 1 Clinical Studies. Investigative Ophthalmology & Visual Science. 58(8). 1952–1952. 5 indexed citations

Locke, Kirsten G., Artur V. Cideciyan, Alessandro Iannaccone, et al.. (2017). Progressive Loss of Rod Sensitivity in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP) due to RHO Pro23His Mutation. Investigative Ophthalmology & Visual Science. 58(8). 3259–3259. 1 indexed citations

Crosby, Jeff, Chenguang Zhao, Chong Jiang, et al.. (2017). Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice. Journal of Cystic Fibrosis. 16(6). 671–680. 68 indexed citations

10.

Grossman, Tamar R., Lisa Hettrick, Robert B. Johnson, et al.. (2015). Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice. Immunobiology. 221(6). 701–708. 27 indexed citations

11.

Billioud, Gaëtan, Robert L. Kruse, Melissa Carrillo, et al.. (2015). In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. Journal of Hepatology. 64(4). 781–789. 42 indexed citations

12.

Yu, Xing, Lynnetta M. Watts, Vara Prasad Manchem, et al.. (2013). Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice. PLoS ONE. 8(7). e66923–e66923. 25 indexed citations

13.

Ren, Jun, Bess A. Marshall, Mike Mueckler, et al.. (1995). Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.. Journal of Clinical Investigation. 95(1). 429–432. 145 indexed citations

14.

Yoo-Warren, H, et al.. (1994). Regulation of Rat Glucagon Receptor Expression. Biochemical and Biophysical Research Communications. 205(1). 347–353. 14 indexed citations

15.

Ellingboe, John W., et al.. (1992). Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides. Journal of Medicinal Chemistry. 35(7). 1176–1183. 31 indexed citations

16.

McCaleb, Michael L. & Janet Sredy. (1992). Metabolic abnormalities of the hyperglycemic obese Zucker rat. Metabolism. 41(5). 522–525. 35 indexed citations

17.

Zask, Arie, et al.. (1990). Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones. Journal of Medicinal Chemistry. 33(5). 1418–1423. 30 indexed citations

18.

McCaleb, Michael L., et al.. (1988). Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat. Journal of Diabetic Complications. 2(1). 16–18. 36 indexed citations

19.

Lockwood, Dean H., Gary R. Hayes, & Michael L. McCaleb. (1987). The Insulin-Resistance Inducing Factor Associated with Uremia. Advances in experimental medicine and biology. 223. 97–104. 2 indexed citations

20.

McCaleb, Michael L. & David B. Donner. (1982). Consequences of 125I-labeled insulin degradation by hepatocytes on the interpretation of receptor binding studies. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 720(2). 147–153. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact